Pure Global

BIOMERIEUX S.A. - Authorized Company ProfileBIOMERIEUX S.A.

Explore comprehensive authorized company profile for BIOMERIEUX S.A. through Pure Global AI's free Colombia medical device database. This company manufactures 86 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Jun 22, 2022 to Apr 08, 2034.

This page provides detailed insights including recent registrations, risk class distribution (III: 14, Unspecified: 2, I: 13, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.

Free Authorized Company Profile
Powered by Pure Global AI
86 Devices
5 Risk Classes
BIOMERIEUX S.A.
BIOMERIEUX S.A.
Authorized Company
86
Total Devices
5
Risk Classes
2022
Earliest
2034
Latest
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Recent Registrations
Latest 20 INVIMA device registrations

VIDAS C. DIFFICILE TOXIN A & B

VIDAS C. DIFFICILE TOXIN A & B

036fe8a14cedfb901f4a31526be7dc9c

II
Apr 08, 2034

VIDAS 3 - ANALIZADOR DE INMUNOENSAYO VIDAS 3

LIVES 3 - LIVES 3 IMMUNOASSAY ANALYZER

0812309589d19397ce55f1fa8a97d632

IIa
Mar 20, 2034

VITEK MS CHCA MATRIX

VITEK MS CHCA MATRIX

bf56f3503633041f436b81bab6964d3d

I
Oct 17, 2033

1. AGAR GARDNERELLA

1. AGAR GARDNERELLA

be00d524013cb3d5d653e5afc2ca01c6

I
Oct 02, 2033

AGAR CHROMID CARBA (CARB)

AGAR CHROMID CARBA (CARB)

d3815b95f74bc5f17b935f26f69e102d

I
Dec 05, 2032

SALINE SOLUTION

SALINE SOLUTION

af2a399d8245ec5e39f78650d9d58671

Apr 21, 2031

ARGENE® SARS-COV-2 R-GENE®

ARGENE® SARS-COV-2 R-GENE®

ce2415ceda5c9944b4a714aa86137d2b

Apr 06, 2030

ETEST FOSFOMYCIN

ETEST FOSFOMYCIN

ac2e9e868dd17e59444015c7ab1a92a2

II
Aug 01, 2029

ETEST ITRACONAZOLE

ETEST ITRACONAZOLE

f1730efd5184251e9dbf8c9d5266072c

II
Aug 01, 2029

VIDAS PTH (1-84)

VIDAS PTH (1-84)

22cf6cb758ceda27108e4c444ef20d32

II
Jun 12, 2029

PREVICOLOR GRAM FUSCHIN SOLUTION RA-4

PREVICOLOR GRAM FUSCHIN SOLUTION RA-4

87187067642694027291642e13312282

I
May 02, 2029

PREVICOLOR GRAM CRYSTAL VIOLET SOLUTION RC

PREVICOLOR GRAM CRYSTAL VIOLET SOLUTION RC

3aecb5f13dff3ad66577dc7ab1ae1d65

I
May 02, 2029

PREVICOLOR GRAM ACETONE SAFRANIN SOLUTION RA-1

PREVICOLOR GRAM ACETONE SAFRANIN SOLUTION RA-1

d4a0eb9c22a2115bb77491f6dc0a6642

I
May 02, 2029

PREVICOLOR GRAM IODINESOLUTION RB

PREVICOLOR GRAM IODINESOLUTION RB

15ca396f5552ae6543404c18ff334914

I
May 02, 2029

PREVICOLOR GRAM ACETONE FUSCHIN SOLUTION RA-3

PREVICOLOR GRAM ACETONE FUSCHIN SOLUTION RA-3

a42e783c116b496ffad71c5c5d9eabbd

I
May 02, 2029

PREVICOLOR GRAM SAFRANIN SOLUTION RA-2

PREVICOLOR GRAM SAFRANIN SOLUTION RA-2

a50b19997a0194ab9c7e404ceff83c82

I
May 02, 2029

CEFTRIAXONE

CEFTRIAXONE

66d763b592c02abae0d127f642c1e43b

II
Feb 19, 2029

CLARITHROMYCIN

CLARITHROMYCIN

a4a461672e77b1e4775f9ddfe610445f

II
Feb 19, 2029

CLINDAMYCIN

CLINDAMYCIN

1e195614cb963356234630c29b6f4d2c

II
Feb 19, 2029

DOXYCYCLINE

DOXYCYCLINE

5c7034fcc6f07d2f889e4a18efe66f2a

II
Feb 19, 2029
Risk Class Distribution
Devices by risk class
II
55
64.0% of total
III
14
16.3% of total
I
13
15.1% of total
Unspecified
2
2.3% of total
IIa
2
2.3% of total